| 摘要: |
| ［摘要］ 非酒精性脂肪性肝病在乳腺癌患者化疗及内分泌治疗期间有较高的发生率，它是患者肝功能损伤或肝酶异常的常见原因，并影响乳腺癌患者的治疗和预后，但其防治尚未引起足够的重视。该文将系统阐述乳腺癌患者辅助治疗期间非酒精性脂肪性肝病的管理与防治，以提高对其认识，并进一步改善乳腺癌患者的生存质量和预后。 |
| 关键词: 乳腺癌 乳腺癌伴随疾病 非酒精性脂肪肝 乳腺肿瘤肝病学 代谢相关脂肪性肝病 |
| DOI：10.3969/j.issn.1674-3806.2020.08.26 |
| 分类号:R 736；R 657 |
| 基金项目: |
|
| Strengthening the comprehensive management of concomitant diseases of breast cancer: non-alcoholic fatty liver disease |
|
TIAN Shen, WU Juan, KONG Ling-quan, et al.
|
|
Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
|
| Abstract: |
| ［Abstract］ Non-alcoholic fatty liver disease(NAFLD) has a high incidence in breast cancer patients during chemotherapy and endocrine therapy. NAFLD is a common case of hepatic dysfunction and abnormal liver enzymes, and therefore affects the therapy and prognosis of breast cancer patients. However, the prevention and treatment of NAFLD has not attracted enough attention. In this paper, we systematically review the management, prevention and treatment of NAFLD in breast cancer patients during adjuvant therapy to raise awareness of NAFLD and further improve the quality of life and prognosis of breast cancer patients. |
| Key words: Breast cancer Concomitant diseases of breast cancer(CDBC) Non-alcoholic fatty liver disease(NAFLD) Breast oncohepatology Metabolic associated fatty liver disease |
